Skip to main
HTFL

HeartFlow Inc (HTFL) Stock Forecast & Price Target

HeartFlow Inc (HTFL) Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 40%
Buy 60%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

HeartFlow Inc demonstrated impressive growth with approximately 48% worldwide FFR-CT volume growth, contributing to a strong 3Q25 performance where revenues reached $46.3 million, marking a 41% increase year-over-year and surpassing projected figures. The company reported significant gross margin improvement, reaching 76.8%, showcasing effective cost management and operational efficiency. As adoption of coronary CT angiography increases and new accounts are added, along with the anticipated revenue from plaque analysis set to begin in 2026, the overall fundamentals supporting HeartFlow's growth outlook remain robust and promising.

Bears say

HeartFlow Inc. has reported significant net losses of $95.7 million and $96.4 million for fiscal years 2023 and 2024, respectively, and anticipates incurring additional substantial losses in the foreseeable future, raising concerns about its potential to achieve profitability. The company's reliance on healthcare providers adhering to specific ACC and AHA guidelines for the adoption of its diagnostic solutions presents a risk, as widespread acceptance of these guidelines among providers is not guaranteed. Additionally, there exists a reimbursement risk; if third-party payors do not provide adequate coverage for the HeartFlow Platform or if reimbursement amounts are reduced, the company's financial condition and growth prospects could be negatively impacted.

HeartFlow Inc (HTFL) has been analyzed by 5 analysts, with a consensus rating of Buy. 40% of analysts recommend a Strong Buy, 60% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of HeartFlow Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About HeartFlow Inc (HTFL) Forecast

Analysts have given HeartFlow Inc (HTFL) a Buy based on their latest research and market trends.

According to 5 analysts, HeartFlow Inc (HTFL) has a Buy consensus rating as of Feb 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $39.20, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $39.20, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

HeartFlow Inc (HTFL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.